Biocorp Production

Biocorp Production Enterprise Value

Delisted

The Enterprise Value (EV) of Biocorp Production (ALCOR.PA) as of Oct 27, 2026 is 157.55 M EUR. In the previous year, Enterprise Value (EV) was 156.79 M EUR — a change of 0.48% (higher).

Enterprise Value

157.55 MEUR

YoY

0.48%

Last updated:

Enterprise Value (EV) of Biocorp Production is 2022 157.55 M EUR. Enterprise Value (EV) of Biocorp Production was 2021 156.79 M EUR. It decreases by 0.48% higher compared to the previous year.

The Biocorp Production Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2015
157.77 M EUR
Jan 1, 2016
152.66 M EUR
Jan 1, 2017
157.62 M EUR
Jan 1, 2018
158.41 M EUR
Jan 1, 2019
156.63 M EUR
Jan 1, 2020
155.32 M EUR
Jan 1, 2021
156.79 M EUR
Jan 1, 2022
157.55 M EUR
The Biocorp Production Enterprise Value history
YEAREnterprise ValueYoY
157.55 MEUR+0.48%
156.79 MEUR+0.95%
155.32 MEUR-0.84%
156.63 MEUR-1.12%
158.41 MEUR+0.50%
157.62 MEUR+3.25%
152.66 MEUR-3.24%
157.77 MEUR-0.12%
157.96 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biocorp Production Stock analysis

What does Biocorp Production do? Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biocorp Production stock

Enterprise Value (EV) of Biocorp Production is 157.55 M EUR in 2022.

Enterprise Value (EV) of Biocorp Production changed from 156.79 M EUR to 157.55 M EUR, representing a 0.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Biocorp Production since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s EUR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' EUR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Biocorp Production with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biocorp Production

All Key Metrics — Biocorp Production